HomeProductsBuilding BlocksHeterocyclic ScaffoldsPyrimidinesBafetinib
Chemical structure of CAS 859212-16-1

Bafetinib

CAS No.859212-16-1
MDL No.MFCD18633200
MFC30H31F3N8O
MW576.60
InChI KeyZGBAJMQHJDFTQJ-DEOSSOPVSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Bafetinib is a biaryl compound.

CAS No.859212-16-1
Product NameBafetinib

Biological Targets

ABL1·LYN

Associated Conditions

prostate cancer·chronic lymphocytic leukemia
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Quercetin as a Lyn kinase inhibitor inhibits IgE-mediated allergic conjunctivitis.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association • Vol. 135 • 2020
PMID: 31672514DOI: 10.1016/j.fct.2019.110924

A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells.

Leukemia • Vol. 24, Issue 1 • 2010
PMID: 19890374DOI: 10.1038/leu.2009.228

Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome-positive leukemias after imatinib resistance or intolerance.

Cancer • Vol. 116, Issue 11 • 2010
PMID: 20310049PMC: PMC2876208DOI: 10.1002/cncr.25079

Documentation

Similar Products